img

Global Gene Therapy Medicinal Products (GTMP) Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gene Therapy Medicinal Products (GTMP) Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Gene Therapy Medicinal Products (GTMP) Market
The global Gene Therapy Medicinal Products (GTMP) market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Gene Therapy Medicinal Products (GTMP) is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Gene Therapy Medicinal Products (GTMP) is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Gene Therapy Medicinal Products (GTMP) is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Gene Therapy Medicinal Products (GTMP) include Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Gene Therapy Medicinal Products (GTMP) market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Gene Therapy Medicinal Products (GTMP), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Therapy Medicinal Products (GTMP), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Therapy Medicinal Products (GTMP) revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Gene Therapy Medicinal Products (GTMP) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Gene Therapy Medicinal Products (GTMP) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc.



By Company


Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Segment by Type
Oral
Injection

Segment by Application


Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Gene Therapy Medicinal Products (GTMP) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Gene Therapy Medicinal Products (GTMP) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy Medicinal Products (GTMP) revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious Disease
1.3.5 Cardiovascular Disease
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Medicinal Products (GTMP) Market Perspective (2018-2034)
2.2 Global Gene Therapy Medicinal Products (GTMP) Growth Trends by Region
2.2.1 Gene Therapy Medicinal Products (GTMP) Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Gene Therapy Medicinal Products (GTMP) Historic Market Size by Region (2018-2024)
2.2.3 Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Region (2024-2034)
2.3 Gene Therapy Medicinal Products (GTMP) Market Dynamics
2.3.1 Gene Therapy Medicinal Products (GTMP) Industry Trends
2.3.2 Gene Therapy Medicinal Products (GTMP) Market Drivers
2.3.3 Gene Therapy Medicinal Products (GTMP) Market Challenges
2.3.4 Gene Therapy Medicinal Products (GTMP) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Therapy Medicinal Products (GTMP) by Players
3.1.1 Global Gene Therapy Medicinal Products (GTMP) Revenue by Players (2018-2024)
3.1.2 Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Players (2018-2024)
3.2 Global Gene Therapy Medicinal Products (GTMP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Therapy Medicinal Products (GTMP), Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio
3.4.1 Global Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Medicinal Products (GTMP) Revenue in 2022
3.5 Global Key Players of Gene Therapy Medicinal Products (GTMP) Head office and Area Served
3.6 Global Key Players of Gene Therapy Medicinal Products (GTMP), Product and Application
3.7 Global Key Players of Gene Therapy Medicinal Products (GTMP), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Medicinal Products (GTMP) Breakdown Data by Type
4.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Type (2018-2024)
4.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2024-2034)
5 Gene Therapy Medicinal Products (GTMP) Breakdown Data by Application
5.1 Global Gene Therapy Medicinal Products (GTMP) Historic Market Size by Application (2018-2024)
5.2 Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Gene Therapy Medicinal Products (GTMP) Market Size (2018-2034)
6.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type
6.2.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024)
6.2.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2034)
6.2.3 North America Gene Therapy Medicinal Products (GTMP) Market Share by Type (2018-2034)
6.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application
6.3.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024)
6.3.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2034)
6.3.3 North America Gene Therapy Medicinal Products (GTMP) Market Share by Application (2018-2034)
6.4 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country
6.4.1 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2018-2024)
6.4.3 North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size (2018-2034)
7.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type
7.2.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024)
7.2.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2034)
7.2.3 Europe Gene Therapy Medicinal Products (GTMP) Market Share by Type (2018-2034)
7.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application
7.3.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024)
7.3.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2034)
7.3.3 Europe Gene Therapy Medicinal Products (GTMP) Market Share by Application (2018-2034)
7.4 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country
7.4.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2018-2024)
7.4.3 Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Therapy Medicinal Products (GTMP) Market Size (2018-2034)
8.2 China Gene Therapy Medicinal Products (GTMP) Market Size by Type
8.2.1 China Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024)
8.2.2 China Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2034)
8.2.3 China Gene Therapy Medicinal Products (GTMP) Market Share by Type (2018-2034)
8.3 China Gene Therapy Medicinal Products (GTMP) Market Size by Application
8.3.1 China Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024)
8.3.2 China Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2034)
8.3.3 China Gene Therapy Medicinal Products (GTMP) Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Gene Therapy Medicinal Products (GTMP) Market Size (2018-2034)
9.2 Asia Gene Therapy Medicinal Products (GTMP) Market Size by Type
9.2.1 Asia Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024)
9.2.2 Asia Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2034)
9.2.3 Asia Gene Therapy Medicinal Products (GTMP) Market Share by Type (2018-2034)
9.3 Asia Gene Therapy Medicinal Products (GTMP) Market Size by Application
9.3.1 Asia Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024)
9.3.2 Asia Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2034)
9.3.3 Asia Gene Therapy Medicinal Products (GTMP) Market Share by Application (2018-2034)
9.4 Asia Gene Therapy Medicinal Products (GTMP) Market Size by Region
9.4.1 Asia Gene Therapy Medicinal Products (GTMP) Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Gene Therapy Medicinal Products (GTMP) Market Size by Region (2018-2024)
9.4.3 Asia Gene Therapy Medicinal Products (GTMP) Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Details
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Introduction
11.1.4 Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
11.1.5 Bluebird Bio Recent Developments
11.2 Sangamo
11.2.1 Sangamo Company Details
11.2.2 Sangamo Business Overview
11.2.3 Sangamo Gene Therapy Medicinal Products (GTMP) Introduction
11.2.4 Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
11.2.5 Sangamo Recent Developments
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
11.3.4 Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
11.3.5 Spark Therapeutics Recent Developments
11.4 Dimension Therapeutics
11.4.1 Dimension Therapeutics Company Details
11.4.2 Dimension Therapeutics Business Overview
11.4.3 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
11.4.4 Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
11.4.5 Dimension Therapeutics Recent Developments
11.5 Avalanche Bio
11.5.1 Avalanche Bio Company Details
11.5.2 Avalanche Bio Business Overview
11.5.3 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Introduction
11.5.4 Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
11.5.5 Avalanche Bio Recent Developments
11.6 Celladon
11.6.1 Celladon Company Details
11.6.2 Celladon Business Overview
11.6.3 Celladon Gene Therapy Medicinal Products (GTMP) Introduction
11.6.4 Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
11.6.5 Celladon Recent Developments
11.7 Vical Inc.
11.7.1 Vical Inc. Company Details
11.7.2 Vical Inc. Business Overview
11.7.3 Vical Inc. Gene Therapy Medicinal Products (GTMP) Introduction
11.7.4 Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
11.7.5 Vical Inc. Recent Developments
11.8 Advantagene
11.8.1 Advantagene Company Details
11.8.2 Advantagene Business Overview
11.8.3 Advantagene Gene Therapy Medicinal Products (GTMP) Introduction
11.8.4 Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
11.8.5 Advantagene Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 5. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 6. Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Gene Therapy Medicinal Products (GTMP) Market Share by Region (2018-2024)
Table 8. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Gene Therapy Medicinal Products (GTMP) Market Share by Region (2024-2034)
Table 10. Gene Therapy Medicinal Products (GTMP) Market Trends
Table 11. Gene Therapy Medicinal Products (GTMP) Market Drivers
Table 12. Gene Therapy Medicinal Products (GTMP) Market Challenges
Table 13. Gene Therapy Medicinal Products (GTMP) Market Restraints
Table 14. Global Gene Therapy Medicinal Products (GTMP) Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Gene Therapy Medicinal Products (GTMP) Revenue Share by Players (2018-2024)
Table 16. Global Top Gene Therapy Medicinal Products (GTMP) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2022)
Table 17. Global Gene Therapy Medicinal Products (GTMP) Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Gene Therapy Medicinal Products (GTMP) Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Gene Therapy Medicinal Products (GTMP), Headquarters and Area Served
Table 20. Global Key Players of Gene Therapy Medicinal Products (GTMP), Product and Application
Table 21. Global Key Players of Gene Therapy Medicinal Products (GTMP), Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2018-2024)
Table 25. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Gene Therapy Medicinal Products (GTMP) Revenue Market Share by Type (2024-2034)
Table 27. Global Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Gene Therapy Medicinal Products (GTMP) Revenue Share by Application (2018-2024)
Table 29. Global Gene Therapy Medicinal Products (GTMP) Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Gene Therapy Medicinal Products (GTMP) Revenue Share by Application (2024-2034)
Table 31. North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2034) & (US$ Million)
Table 33. North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2034) & (US$ Million)
Table 35. North America Gene Therapy Medicinal Products (GTMP) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 36. North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2034) & (US$ Million)
Table 40. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2034) & (US$ Million)
Table 42. Europe Gene Therapy Medicinal Products (GTMP) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 43. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034) & (US$ Million)
Table 45. China Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2034) & (US$ Million)
Table 47. China Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2034) & (US$ Million)
Table 49. Asia Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2034) & (US$ Million)
Table 51. Asia Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2034) & (US$ Million)
Table 53. Asia Gene Therapy Medicinal Products (GTMP) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 54. Asia Gene Therapy Medicinal Products (GTMP) Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Gene Therapy Medicinal Products (GTMP) Market Size by Region (2024-2034) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Type (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Application (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 61. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size by Country (2024-2034) & (US$ Million)
Table 63. Bluebird Bio Company Details
Table 64. Bluebird Bio Business Overview
Table 65. Bluebird Bio Gene Therapy Medicinal Products (GTMP) Product
Table 66. Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024) & (US$ Million)
Table 67. Bluebird Bio Recent Developments
Table 68. Sangamo Company Details
Table 69. Sangamo Business Overview
Table 70. Sangamo Gene Therapy Medicinal Products (GTMP) Product
Table 71. Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024) & (US$ Million)
Table 72. Sangamo Recent Developments
Table 73. Spark Therapeutics Company Details
Table 74. Spark Therapeutics Business Overview
Table 75. Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Product
Table 76. Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024) & (US$ Million)
Table 77. Spark Therapeutics Recent Developments
Table 78. Dimension Therapeutics Company Details
Table 79. Dimension Therapeutics Business Overview
Table 80. Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Product
Table 81. Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024) & (US$ Million)
Table 82. Dimension Therapeutics Recent Developments
Table 83. Avalanche Bio Company Details
Table 84. Avalanche Bio Business Overview
Table 85. Avalanche Bio Gene Therapy Medicinal Products (GTMP) Product
Table 86. Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024) & (US$ Million)
Table 87. Avalanche Bio Recent Developments
Table 88. Celladon Company Details
Table 89. Celladon Business Overview
Table 90. Celladon Gene Therapy Medicinal Products (GTMP) Product
Table 91. Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024) & (US$ Million)
Table 92. Celladon Recent Developments
Table 93. Vical Inc. Company Details
Table 94. Vical Inc. Business Overview
Table 95. Vical Inc. Gene Therapy Medicinal Products (GTMP) Product
Table 96. Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024) & (US$ Million)
Table 97. Vical Inc. Recent Developments
Table 98. Advantagene Company Details
Table 99. Advantagene Business Overview
Table 100. Advantagene Gene Therapy Medicinal Products (GTMP) Product
Table 101. Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2018-2024) & (US$ Million)
Table 102. Advantagene Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Gene Therapy Medicinal Products (GTMP) Market Share by Type: 2022 VS 2034
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 6. Global Gene Therapy Medicinal Products (GTMP) Market Share by Application: 2022 VS 2034
Figure 7. Cancer Case Studies
Figure 8. Monogenic Case Studies
Figure 9. Infectious Disease Case Studies
Figure 10. Cardiovascular Disease Case Studies
Figure 11. Other Case Studies
Figure 12. Gene Therapy Medicinal Products (GTMP) Report Years Considered
Figure 13. Global Gene Therapy Medicinal Products (GTMP) Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Gene Therapy Medicinal Products (GTMP) Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Gene Therapy Medicinal Products (GTMP) Market Share by Region: 2022 VS 2034
Figure 16. Global Gene Therapy Medicinal Products (GTMP) Market Share by Players in 2022
Figure 17. Global Top Gene Therapy Medicinal Products (GTMP) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Gene Therapy Medicinal Products (GTMP) Revenue in 2022
Figure 19. North America Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Gene Therapy Medicinal Products (GTMP) Market Share by Type (2018-2034)
Figure 21. North America Gene Therapy Medicinal Products (GTMP) Market Share by Application (2018-2034)
Figure 22. North America Gene Therapy Medicinal Products (GTMP) Market Share by Country (2018-2034)
Figure 23. United States Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Gene Therapy Medicinal Products (GTMP) Market Size YoY (2018-2034) & (US$ Million)
Figure 26. Europe Gene Therapy Medicinal Products (GTMP) Market Share by Type (2018-2034)
Figure 27. Europe Gene Therapy Medicinal Products (GTMP) Market Share by Application (2018-2034)
Figure 28. Europe Gene Therapy Medicinal Products (GTMP) Market Share by Country (2018-2034)
Figure 29. Germany Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. France Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. U.K. Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Italy Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Russia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Nordic Countries Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. China Gene Therapy Medicinal Products (GTMP) Market Size YoY (2018-2034) & (US$ Million)
Figure 36. China Gene Therapy Medicinal Products (GTMP) Market Share by Type (2018-2034)
Figure 37. China Gene Therapy Medicinal Products (GTMP) Market Share by Application (2018-2034)
Figure 38. Asia Gene Therapy Medicinal Products (GTMP) Market Size YoY (2018-2034) & (US$ Million)
Figure 39. Asia Gene Therapy Medicinal Products (GTMP) Market Share by Type (2018-2034)
Figure 40. Asia Gene Therapy Medicinal Products (GTMP) Market Share by Application (2018-2034)
Figure 41. Asia Gene Therapy Medicinal Products (GTMP) Market Share by Region (2018-2034)
Figure 42. Japan Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. South Korea Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. China Taiwan Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Southeast Asia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. India Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Australia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Size YoY (2018-2034) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Type (2018-2034)
Figure 50. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Application (2018-2034)
Figure 51. Middle East, Africa, and Latin America Gene Therapy Medicinal Products (GTMP) Market Share by Country (2018-2034)
Figure 52. Brazil Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Mexico Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Turkey Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Israel Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. GCC Countries Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 58. Bluebird Bio Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
Figure 59. Sangamo Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
Figure 60. Spark Therapeutics Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
Figure 61. Dimension Therapeutics Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
Figure 62. Avalanche Bio Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
Figure 63. Celladon Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
Figure 64. Vical Inc. Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
Figure 65. Advantagene Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2018-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed